FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
+1.27%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$40M
AUM Growth
+$40M
(-1.7%)
Cap. Flow
+$38.6K
Cap. Flow
% of AUM
0.1%
Top 10 Holdings %
Top 10 Hldgs %
49.37%
Holding
144
New
32
Increased
8
Reduced
21
Closed
23
Top Buys
| 1 |
Incyte
INCY
|
$3.26M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$2.3M |
| 3 |
Puma Biotechnology
PBYI
|
$1.37M |
| 4 |
Children's Place
PLCE
|
$1.3M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$1.18M |
Top Sells
| 1 |
General Mills
GIS
|
$2.38M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$2.31M |
| 3 |
Amgen
AMGN
|
$2.08M |
| 4 |
Abbott
ABT
|
$1.83M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$1.62M |
Sector Composition
| 1 | Healthcare | 69.4% |
| 2 | Consumer Discretionary | 11.79% |
| 3 | Consumer Staples | 10.38% |
| 4 | Communication Services | 1.65% |
| 5 | Materials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
1
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.74M | 5.64% | 36,847 +3,290 | +10% | +$334K |
|
|
2
Incyte
INCY
$16.5B
| $3.26M | 4.91% | +27,887 | New | +$3.26M |
|
|
3
Teva Pharmaceuticals
TEVA
$21.1B
| $2.3M | 3.47% | +130,723 | New | +$2.3M |
|
|
TSRO
4
DELISTED
TESARO, Inc.
TSRO
| $1.87M | 2.81% | 14,462 +3,657 | +34% | +$472K |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.8M | 2.71% | 21,787 -19,713 | -48% | -$1.62M |
|
6
Alibaba
BABA
$322B
| $1.71M | 2.58% | 9,900 | – | – |
|
|
7
Puma Biotechnology
PBYI
$254M
| $1.37M | 2.06% | +11,438 | New | +$1.37M |
|
|
8
Children's Place
PLCE
$112M
| $1.3M | 1.96% | +11,000 | New | +$1.3M |
|
9
iShares Biotechnology ETF
IBB
$5.6B
| $1.22M | 1.84% | 3,662 -3,085 | -46% | -$1.03M |
|
|
ICPT
10
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.18M | 1.77% | +20,264 | New | +$1.18M |
|
11
Kimberly-Clark
KMB
$42.8B
| $1.14M | 1.72% | +9,700 | New | +$1.14M |
|
12
Nike
NKE
$114B
| $1.06M | 1.59% | +20,400 | New | +$1.06M |
|
13
Henry Schein
HSIC
$8.44B
| $1.01M | 1.53% | +12,348 | New | +$1.01M |
|
|
ZGNX
14
DELISTED
Zogenix, Inc.
ZGNX
| $939K | 1.42% | +26,778 | New | +$939K |
|
15
Gilead Sciences
GILD
$140B
| $938K | 1.41% | +11,581 | New | +$938K |
|
|
ALXN
16
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $914K | 1.38% | +6,518 | New | +$914K |
|
17
AB InBev
BUD
$122B
| $847K | 1.28% | 7,100 -109 | -2% | -$13K |
|
|
18
Abbott
ABT
$231B
| $843K | 1.27% | 15,800 -34,270 | -68% | -$1.83M |
|
|
DBVT
19
DBV Technologies
DBVT
$264M
| $786K | 1.18% | +18,524 | New | +$786K |
|
20
Mondelez International
MDLZ
$79.5B
| $720K | 1.09% | 17,700 -15,654 | -47% | -$637K |
|
|
TWX
21
DELISTED
Time Warner Inc
TWX
| $660K | 0.99% | 6,445 +3,995 | +163% | +$409K |
|
22
SCYNEXIS
SCYX
$34.9M
| $581K | 0.88% | 241,236 | – | – |
|
|
AIMT
23
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $573K | 0.86% | +23,100 | New | +$573K |
|
24
Sarepta Therapeutics
SRPT
$1.78B
| $568K | 0.86% | 12,522 -3,471 | -22% | -$157K |
|
25
DaVita
DVA
$9.85B
| $564K | 0.85% | 9,500 -5,139 | -35% | -$305K |
|